Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRAF | P15056 | 7/20 | 0.45 |
| ▸ | KDR | P35968 | 2/20 | 0.42 |
| ▸ | PTK2 | Q05397 | 5/20 | 0.42 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.40 |
| ▸ | CDK9 | P50750 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CDC7 | O00311 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | TTK | P33981 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19714696 | 1.00 | BRAF (0.45) | BRAFKDRPTK2CCNT1CDK9 | |
| SCHEMBL30930115 | 0.89 | KDR (0.43) | KDRPTK2CCNT1CDK9CDC7 | |
| SCHEMBL18586191 | 0.89 | KDR (0.43) | KDRPTK2CCNT1CDK9CDC7 | |
| SCHEMBL19725771 | 0.88 | BRAF (0.45) | BRAFKDRPTK2CCNT1CDK9 | |
| SCHEMBL29222373 | 0.86 | BRAF (0.44) | BRAFKDRPTK2CCNT1CDK9 | |
| SCHEMBL17888153 | 0.85 | EGFR (0.49) | BRAFPTK2EGFR | |
| SCHEMBL35210303 | 0.84 | CDC7 (0.44) | KDRPTK2CCNT1CDK9CDC7 | |
| SCHEMBL19089534 | 0.84 | CDC7 (0.44) | KDRPTK2CCNT1CDK9CDC7 | |
| SCHEMBL19089467 | 0.83 | KDR (0.44) | KDRPTK2EGFR | |
| SCHEMBL19337070 | 0.82 | EGFR (0.43) | KDRPTK2CCNT1CDK9EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113563332-B | Novel pyrimidines as EGFR inhibitors and methods of treating disorders | 达纳－法伯癌症研究所公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-117979968-A | EGFR inhibitors (1H-pyrrolo [2,3-b ] pyridin-1-yl) pyrimidin-2-yl-amino-phenyl-acrylamides for the treatment of brain tumors | 丹娜法伯癌症研究院 | 2024-05-03 | — | — | CN | disclosed |